data_1jnt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jnt _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.535 ' CB ' ' HG2' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.214 0.53 . . . . 3.7999999999999998 110.15 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -60.04 -56.37 22.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 4.9400000000000004 109.824 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 91' ' ' ARG . 20.7 p -145.97 157.36 43.88 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 116.08 -0.509 . . . . 2.0600000000000001 109.634 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . . . -129.49 150.03 51.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.026 -1.046 . . . . 1.28 110.459 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 50' ' ' GLY . . . -95.63 121.36 37.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 1.22 109.05 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.575 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . . . -135.23 136.64 41.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.554 -1.341 . . . . 1.1499999999999999 111.827 -168.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 79.6 mt -99.47 139.68 34.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 1.77 108.582 167.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.575 ' NE2' ' CB ' ' A' ' 6' ' ' ALA . 31.2 m-70 -134.79 134.03 40.46 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.593 -1.317 . . . . 1.6899999999999999 111.573 -175.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.568 ' HB ' ' CG2' ' A' ' 85' ' ' ILE . 77.3 mt -120.01 125.33 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 1.1100000000000001 109.652 167.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.596 ' HG ' ' CD2' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -100.01 120.04 39.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 1.8999999999999999 109.666 178.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 1.8 t -101.67 131.72 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 1.2 109.919 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -63.77 -39.98 95.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 3.3500000000000001 110.615 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -140.0 156.89 46.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.136 -0.977 . . . . 1.8200000000000001 110.513 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -59.96 -39.98 87.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.435 -0.79 . . . . 1.8400000000000001 110.377 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -52.29 -43.95 64.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.19 -0.944 . . . . 2.9300000000000002 110.3 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.537 ' HB3' ' CG1' ' A' ' 11' ' ' VAL . 2.1 tt -68.65 -40.02 80.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.079 -1.013 . . . . 1.55 109.38 176.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -59.34 -40.01 85.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.319 -0.863 . . . . 1.1399999999999999 109.988 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.514 ' HA ' HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -59.69 -46.63 88.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 2.1400000000000001 109.504 175.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -60.02 -39.97 87.68 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.288 -0.882 . . . . 1.3600000000000001 109.746 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -65.5 -44.16 87.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.898 . . . . 1.8 110.211 178.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.6 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -57.88 -53.2 60.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 2.1800000000000002 110.197 -178.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.475 ' HG2' ' OD1' ' A' ' 26' ' ' ASN . 86.4 tt0 -62.51 -40.03 95.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 2.4100000000000001 110.765 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -59.98 -41.89 93.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.087 -1.008 . . . . 2.8700000000000001 111.004 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 28' ' ' ALA . 83.6 mt -63.9 -47.55 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.078 -1.014 . . . . 1.3500000000000001 110.49 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -62.84 -51.48 66.89 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.799 -1.188 . . . . 3.2999999999999998 110.153 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.475 ' OD1' ' HG2' ' A' ' 22' ' ' GLU . 27.1 m120 -61.11 -41.32 96.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.262 -0.899 . . . . 2.1800000000000002 110.785 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.669 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . -105.66 -64.72 0.64 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.458 -1.457 . . . . 0.79000000000000004 109.458 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.669 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . 89.77 96.61 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.653 0.739 . . . . 1.23 110.581 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.473 ' O ' ' CG ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -178.05 83.04 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.595 -0.691 . . . . 1.5600000000000001 109.533 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -67.19 -43.7 81.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 2.5899999999999999 110.676 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.89 -51.2 53.51 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.83 -1.308 . . . . 0.65000000000000002 109.83 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 29.5 mttm -66.71 -38.39 86.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.017 -1.284 . . . . 3.4399999999999999 110.891 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.527 ' CD1' HG12 ' A' ' 24' ' ' ILE . 71.2 mt -62.09 -40.04 94.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.861 -1.149 . . . . 2.3999999999999999 110.165 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.31 93.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.933 -1.105 . . . . 1.26 109.472 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 59.3 tttp -59.98 -46.3 89.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.38 -0.825 . . . . 3.54 110.793 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -70.02 -40.36 75.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.166 -0.958 . . . . 3.2400000000000002 111.895 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -102.56 -23.83 13.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.573 -1.33 . . . . 2.1600000000000001 111.655 -168.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.536 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 35.4 t -59.9 -43.69 94.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.879 -1.138 . . . . 1.52 110.32 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 38' ' ' SER . 19.8 tt 37.6 29.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 2.5099999999999998 110.547 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.507 ' N ' ' O ' ' A' ' 38' ' ' SER . 14.2 p -125.17 169.06 11.87 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.945 . . . . 1.28 110.075 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -59.24 -23.47 69.77 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.977 1.514 . . . . 1.4299999999999999 110.042 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.578 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -104.84 27.98 7.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.353 -0.842 . . . . 1.4299999999999999 109.751 176.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' HA2' ' OG ' ' A' ' 38' ' ' SER . . . -75.59 -56.72 4.48 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.59 -1.804 . . . . 0.83999999999999997 108.59 173.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -60.39 -39.94 89.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -1.134 . . . . 4.2800000000000002 110.626 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -96.34 -44.19 7.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.927 -1.108 . . . . 3.4300000000000002 110.736 -174.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -61.14 -36.71 92.77 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.532 -1.427 . . . . 1.28 109.532 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.95 0.45 21.98 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.706 -1.357 . . . . 0.95999999999999996 109.706 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -170.38 78.01 0.08 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.241 -1.152 . . . . 1.54 109.187 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.41 ' HA ' ' HD2' ' A' ' 45' ' ' ARG . 6.3 mt -82.73 -4.13 57.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.562 -0.711 . . . . 1.3200000000000001 110.204 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 70.01 -137.33 28.13 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.103 -1.599 . . . . 0.69999999999999996 109.103 -176.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 2.6 mt-10 -104.24 135.07 46.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -1.097 . . . . 1.73 110.681 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 6' ' ' ALA . 4.1 p90 -147.61 160.15 42.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.563 -0.711 . . . . 1.23 109.593 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' A' ' 56' ' ' GLN . 6.4 ptm180 -90.02 170.28 10.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 4.7599999999999998 110.579 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -61.04 -14.36 22.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.244 -0.91 . . . . 5.6500000000000004 110.612 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.405 ' C ' ' HG2' ' A' ' 56' ' ' GLN . . . -102.69 60.46 0.52 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.502 -1.439 . . . . 3.3999999999999999 109.502 -176.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.554 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 4.3 mm-40 -132.92 -61.96 0.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.066 -1.256 . . . . 2.2999999999999998 109.735 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.479 ' HE2' HG13 ' A' ' 58' ' ' VAL . 5.9 ttp -106.16 -66.03 1.03 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.339 -0.944 . . . . 6.4699999999999998 111.243 -165.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG23 ' HD2' ' A' ' 59' ' ' PRO . 2.9 p -154.07 137.69 10.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.898 -1.126 . . . . 2.0099999999999998 110.599 -170.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.56 ' O ' ' N ' ' A' ' 61' ' ' PHE . 10.8 Cg_endo -57.98 -52.13 6.53 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.979 1.515 . . . . 1.6399999999999999 110.768 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -35.53 -29.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.475 -0.766 . . . . 1.3200000000000001 110.46 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.56 ' N ' ' O ' ' A' ' 59' ' ' PRO . 45.9 t80 -58.05 -40.3 80.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.136 -0.977 . . . . 1.3700000000000001 110.152 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 59' ' ' PRO . 13.1 t70 -59.98 -40.64 89.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.035 -1.041 . . . . 1.8799999999999999 109.739 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -59.98 -50.55 73.32 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.399 -0.92 . . . . 4.1399999999999997 110.53 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.533 HG12 ' O ' ' A' ' 61' ' ' PHE . 7.1 p -70.83 -47.16 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.075 -1.016 . . . . 1.74 110.657 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.17 -30.04 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.797 -1.189 . . . . 1.51 109.318 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 4.8 m-85 -96.29 2.67 53.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.38 -0.825 . . . . 2.7999999999999998 109.823 174.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.49 ' CB ' ' HA ' ' A' ' 64' ' ' VAL . 20.1 t -94.76 -70.54 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 1.52 109.521 174.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.8 m -106.03 142.61 25.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 2.29 109.952 174.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.1 164.54 35.4 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.916 1.482 . . . . 1.6399999999999999 110.487 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.533 ' CG1' HD13 ' A' ' 71' ' ' LEU . 7.1 p -57.13 170.56 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 2.3500000000000001 109.955 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.533 HD13 ' CG1' ' A' ' 70' ' ' VAL . 3.5 mp 60.01 35.15 21.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.29 -0.881 . . . . 2.1899999999999999 110.021 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . 16.3 tt0 -163.47 93.48 1.11 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 2.0099999999999998 109.95 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 72' ' ' GLU . 6.5 Cg_endo -53.46 144.25 51.75 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.935 1.492 . . . . 1.1899999999999999 110.47 -177.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 m -139.83 143.34 36.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -0.878 . . . . 1.22 110.272 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.438 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 136.63 -178.48 18.83 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.368 -1.493 . . . . 0.52000000000000002 109.368 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.64 136.52 45.08 Favored 'Cis proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.364 -2.348 . . . . 0.66000000000000003 110.555 -1.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 55.7 tp -100.43 160.22 14.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.232 -0.918 . . . . 2.4100000000000001 110.42 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.439 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 45.5 m80 -77.33 133.67 38.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.167 -0.958 . . . . 3.2599999999999998 111.051 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.478 ' CG2' ' CE1' ' A' ' 84' ' ' HIS . 6.2 t -147.72 158.3 43.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -0.922 . . . . 1.3300000000000001 109.75 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -60.05 -30.41 69.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.075 -1.016 . . . . 3.5499999999999998 110.728 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -79.89 -10.02 59.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.094 -1.004 . . . . 1.4099999999999999 110.704 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.461 ' O ' HG21 ' A' ' 79' ' ' THR . . . 145.83 -120.06 1.28 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.237 -1.545 . . . . 0.68000000000000005 109.237 -177.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -129.77 129.99 44.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -1.117 . . . . 1.6499999999999999 109.736 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.596 ' CD2' ' HG ' ' A' ' 10' ' ' LEU . 40.3 m170 -103.64 124.45 48.86 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.915 . . . . 0.76000000000000001 110.796 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.568 ' CG2' ' HB ' ' A' ' 9' ' ' ILE . 3.2 tt -108.56 127.72 64.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.891 -1.131 . . . . 1.1799999999999999 109.161 168.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.531 HG12 ' ND1' ' A' ' 8' ' ' HIS . 66.4 mt -129.99 133.84 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.987 -1.071 . . . . 1.1899999999999999 110.994 -169.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 14.6 ttmt -100.03 128.88 46.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 2.77 109.375 170.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.438 ' O ' HD22 ' A' ' 89' ' ' LEU . 23.3 t -106.12 131.65 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 1.48 110.631 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 91' ' ' ARG . 43.7 mt -139.29 -167.68 2.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.343 -0.848 . . . . 1.4099999999999999 109.273 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.47 ' C ' ' O ' ' A' ' 89' ' ' LEU . 53.0 m-85 32.02 -86.73 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 122.062 -0.399 . . . . 3.0499999999999998 111.492 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 89' ' ' LEU . 67.0 ttt180 60.05 48.67 8.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.736 -1.227 . . . . 3.6099999999999999 110.827 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.996 -1.002 . . . . 4.0 110.154 175.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.559 ' CB ' ' HG2' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.214 0.53 . . . . 3.3799999999999999 110.15 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' C ' HG23 ' A' ' 3' ' ' THR . 93.4 mttt -60.04 -56.37 22.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 4.6399999999999997 109.824 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 91' ' ' ARG . 20.7 p -145.97 157.36 43.88 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 116.08 -0.509 . . . . 1.6899999999999999 109.634 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -129.49 150.03 51.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.026 -1.046 . . . . 0.64000000000000001 110.459 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.605 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -95.63 121.36 37.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.5 109.05 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.841 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -135.23 136.64 41.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.554 -1.341 . . . . 0.44 111.827 -168.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.008 HD12 ' HD2' ' A' ' 87' ' ' LYS . 79.6 mt -99.47 139.68 34.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 1.1799999999999999 108.582 167.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.841 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 31.2 m-70 -134.79 134.03 40.46 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.593 -1.317 . . . . 1.28 111.573 -175.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.699 ' HB ' HG22 ' A' ' 85' ' ' ILE . 77.3 mt -120.01 125.33 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.34999999999999998 109.652 167.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -100.01 120.04 39.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 1.1699999999999999 109.666 178.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.674 HG13 HD22 ' A' ' 16' ' ' LEU . 1.8 t -101.67 131.72 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.76000000000000001 109.919 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -63.77 -39.98 95.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 2.8599999999999999 110.615 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -140.0 156.89 46.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.136 -0.977 . . . . 1.6499999999999999 110.513 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -59.96 -39.98 87.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.435 -0.79 . . . . 1.8400000000000001 110.377 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -52.29 -43.95 64.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.19 -0.944 . . . . 2.5 110.3 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.674 HD22 HG13 ' A' ' 11' ' ' VAL . 2.1 tt -68.65 -40.02 80.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.079 -1.013 . . . . 0.85999999999999999 109.38 176.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.945 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.34 -40.01 85.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.319 -0.863 . . . . 0.40999999999999998 109.988 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -46.63 88.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 1.6100000000000001 109.504 175.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 64.1 t0 -60.02 -39.97 87.68 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.288 -0.882 . . . . 1.3600000000000001 109.746 174.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.86 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -65.5 -44.16 87.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.898 . . . . 1.1100000000000001 110.211 178.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.945 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -57.88 -53.2 60.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 1.55 110.197 -178.462 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.501 ' HG2' ' OD1' ' A' ' 26' ' ' ASN . 86.4 tt0 -62.51 -40.03 95.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 2.4100000000000001 110.765 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.8 tp60 -59.98 -41.89 93.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.087 -1.008 . . . . 2.3500000000000001 111.004 -172.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 28' ' ' ALA . 83.6 mt -63.9 -47.55 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.078 -1.014 . . . . 0.63 110.49 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -62.84 -51.48 66.89 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.799 -1.188 . . . . 2.9300000000000002 110.153 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.501 ' OD1' ' HG2' ' A' ' 22' ' ' GLU . 27.1 m120 -61.11 -41.32 96.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.262 -0.899 . . . . 1.79 110.785 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.823 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.66 -64.72 0.64 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.458 -1.457 . . . . 0.71999999999999997 109.458 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.823 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 89.77 96.61 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.653 0.739 . . . . 1.21 110.581 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.473 ' O ' ' CG ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -178.05 83.04 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.595 -0.691 . . . . 1.5600000000000001 109.533 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -67.19 -43.7 81.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 2.1000000000000001 110.676 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.89 -51.2 53.51 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.83 -1.308 . . . . 0.56000000000000005 109.83 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 29.5 mttm -66.71 -38.39 86.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.017 -1.284 . . . . 2.9500000000000002 110.891 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.55 ' CD1' HG12 ' A' ' 24' ' ' ILE . 71.2 mt -62.09 -40.04 94.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.861 -1.149 . . . . 1.96 110.165 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.31 93.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.933 -1.105 . . . . 0.55000000000000004 109.472 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 59.3 tttp -59.98 -46.3 89.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.38 -0.825 . . . . 3.0800000000000001 110.793 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -70.02 -40.36 75.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.166 -0.958 . . . . 2.8500000000000001 111.895 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -102.56 -23.83 13.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.573 -1.33 . . . . 1.52 111.655 -168.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.653 ' O ' HG22 ' A' ' 39' ' ' ILE . 35.4 t -59.9 -43.69 94.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.879 -1.138 . . . . 1.25 110.32 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 38' ' ' SER . 19.8 tt 37.6 29.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 2.0499999999999998 110.547 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.507 ' N ' ' O ' ' A' ' 38' ' ' SER . 14.2 p -125.17 169.06 11.87 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.945 . . . . 1.1499999999999999 110.075 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -59.24 -23.47 69.77 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.977 1.514 . . . . 1.25 110.042 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.578 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -104.84 27.98 7.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.353 -0.842 . . . . 1.23 109.751 176.28 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.535 ' HA2' ' OG ' ' A' ' 38' ' ' SER . . . -75.59 -56.72 4.48 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.59 -1.804 . . . . 0.75 108.59 173.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -60.39 -39.94 89.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -1.134 . . . . 3.7000000000000002 110.626 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -96.34 -44.19 7.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.927 -1.108 . . . . 2.9900000000000002 110.736 -174.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -61.14 -36.71 92.77 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.532 -1.427 . . . . 1.1000000000000001 109.532 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.95 0.45 21.98 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.706 -1.357 . . . . 0.95999999999999996 109.706 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -170.38 78.01 0.08 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.241 -1.152 . . . . 1.54 109.187 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 45' ' ' ARG . 6.3 mt -82.73 -4.13 57.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.562 -0.711 . . . . 0.70999999999999996 110.204 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 70.01 -137.33 28.13 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.103 -1.599 . . . . 0.60999999999999999 109.103 -176.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 2.6 mt-10 -104.24 135.07 46.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -1.097 . . . . 1.73 110.681 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.701 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 4.1 p90 -147.61 160.15 42.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.563 -0.711 . . . . 0.92000000000000004 109.593 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' A' ' 56' ' ' GLN . 6.4 ptm180 -90.02 170.28 10.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 4.1299999999999999 110.579 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -61.04 -14.36 22.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.244 -0.91 . . . . 5.04 110.612 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.401 ' C ' ' HG2' ' A' ' 56' ' ' GLN . . . -102.69 60.46 0.52 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.502 -1.439 . . . . 2.8399999999999999 109.502 -176.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.554 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 4.3 mm-40 -132.92 -61.96 0.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.066 -1.256 . . . . 2.02 109.735 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.527 ' HB3' HG12 ' A' ' 58' ' ' VAL . 5.9 ttp -106.16 -66.03 1.03 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.339 -0.944 . . . . 6.2199999999999998 111.243 -165.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.527 HG12 ' HB3' ' A' ' 57' ' ' MET . 2.9 p -154.07 137.69 10.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.898 -1.126 . . . . 1.78 110.599 -170.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.56 ' O ' ' N ' ' A' ' 61' ' ' PHE . 10.8 Cg_endo -57.98 -52.13 6.53 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.979 1.515 . . . . 1.3400000000000001 110.768 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -35.53 -29.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.475 -0.766 . . . . 0.73999999999999999 110.46 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.56 ' N ' ' O ' ' A' ' 59' ' ' PRO . 45.9 t80 -58.05 -40.3 80.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.136 -0.977 . . . . 1.1799999999999999 110.152 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' PRO . 13.1 t70 -59.98 -40.64 89.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.035 -1.041 . . . . 1.8799999999999999 109.739 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 67' ' ' SER . 64.8 mttm -59.98 -50.55 73.32 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.399 -0.92 . . . . 3.7000000000000002 110.53 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.667 HG23 HG21 ' A' ' 74' ' ' THR . 7.1 p -70.83 -47.16 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.075 -1.016 . . . . 1.1899999999999999 110.657 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.535 ' N ' HG13 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -53.17 -30.04 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.797 -1.189 . . . . 0.97999999999999998 109.318 175.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 4.8 m-85 -96.29 2.67 53.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.38 -0.825 . . . . 2.2999999999999998 109.823 174.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 64' ' ' VAL . 20.1 t -94.76 -70.54 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 1.23 109.521 174.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.8 m -106.03 142.61 25.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 1.8300000000000001 109.952 174.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.1 164.54 35.4 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.916 1.482 . . . . 1.6399999999999999 110.487 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.864 HG13 HD12 ' A' ' 71' ' ' LEU . 7.1 p -57.13 170.56 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 1.74 109.955 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.864 HD12 HG13 ' A' ' 70' ' ' VAL . 3.5 mp 60.01 35.15 21.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.29 -0.881 . . . . 1.71 110.021 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . 16.3 tt0 -163.47 93.48 1.11 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 2.0099999999999998 109.95 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 72' ' ' GLU . 6.5 Cg_endo -53.46 144.25 51.75 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.935 1.492 . . . . 0.87 110.47 -177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.667 HG21 HG23 ' A' ' 64' ' ' VAL . 22.9 m -139.83 143.34 36.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -0.878 . . . . 0.64000000000000001 110.272 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 136.63 -178.48 18.83 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.368 -1.493 . . . . 0.52000000000000002 109.368 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.538 ' HG3' HD11 ' A' ' 21' ' ' LEU . 46.0 Cg_endo -73.64 136.52 45.08 Favored 'Cis proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.364 -2.348 . . . . 0.66000000000000003 110.555 -1.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 55.7 tp -100.43 160.22 14.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.232 -0.918 . . . . 1.8999999999999999 110.42 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.443 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 90.8 m-70 -77.33 133.67 38.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.167 -0.958 . . . . 2.52 111.051 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.649 HG21 ' CE1' ' A' ' 84' ' ' HIS . 6.2 t -147.72 158.3 43.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -0.922 . . . . 0.73999999999999999 109.75 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -60.05 -30.41 69.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.075 -1.016 . . . . 3.0099999999999998 110.728 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -79.89 -10.02 59.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.094 -1.004 . . . . 1.26 110.704 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.83 -120.06 1.28 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.237 -1.545 . . . . 0.60999999999999999 109.237 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -129.77 129.99 44.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -1.117 . . . . 1.4299999999999999 109.736 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.649 ' CE1' HG21 ' A' ' 79' ' ' THR . 10.4 m-70 -103.64 124.45 48.86 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.915 . . . . 0.60999999999999999 110.796 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.699 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.2 tt -108.56 127.72 64.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.891 -1.131 . . . . 0.34999999999999998 109.161 168.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.537 HG12 ' ND1' ' A' ' 8' ' ' HIS . 66.4 mt -129.99 133.84 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.987 -1.071 . . . . 0.46000000000000002 110.994 -169.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 1.008 ' HD2' HD12 ' A' ' 7' ' ' LEU . 14.6 ttmt -100.03 128.88 46.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 2.2400000000000002 109.375 170.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.807 ' O ' HD23 ' A' ' 89' ' ' LEU . 23.3 t -106.12 131.65 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.88 110.631 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 88' ' ' VAL . 43.7 mt -139.29 -167.68 2.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.343 -0.848 . . . . 0.75 109.273 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 53.0 m-85 32.02 -86.73 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 122.062 -0.399 . . . . 2.9300000000000002 111.492 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 89' ' ' LEU . 67.0 ttt180 60.05 48.67 8.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.736 -1.227 . . . . 3.0899999999999999 110.827 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 91' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.996 -1.002 . . . . 3.75 110.154 175.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.788 ' HB1' HD22 ' A' ' 92' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.214 0.53 . . . . 3.3799999999999999 110.15 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' C ' HG23 ' A' ' 3' ' ' THR . 93.4 mttt -60.04 -56.37 22.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 4.6399999999999997 109.824 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 91' ' ' ARG . 20.7 p -145.97 157.36 43.88 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 116.08 -0.509 . . . . 1.6899999999999999 109.634 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 51' ' ' GLU . . . -129.49 150.03 51.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.026 -1.046 . . . . 0.64000000000000001 110.459 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.605 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . . . -95.63 121.36 37.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.5 109.05 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.841 ' HB1' ' NE2' ' A' ' 8' ' ' HIS . . . -135.23 136.64 41.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.554 -1.341 . . . . 0.44 111.827 -168.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.008 HD12 ' HD2' ' A' ' 87' ' ' LYS . 79.6 mt -99.47 139.68 34.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 1.1799999999999999 108.582 167.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.841 ' NE2' ' HB1' ' A' ' 6' ' ' ALA . 31.2 m-70 -134.79 134.03 40.46 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.593 -1.317 . . . . 1.28 111.573 -175.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.699 ' HB ' HG22 ' A' ' 85' ' ' ILE . 77.3 mt -120.01 125.33 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.34999999999999998 109.652 167.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -100.01 120.04 39.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 1.1699999999999999 109.666 178.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.674 HG13 HD22 ' A' ' 16' ' ' LEU . 1.8 t -101.67 131.72 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.76000000000000001 109.919 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -63.77 -39.98 95.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 2.8599999999999999 110.615 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -140.0 156.89 46.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.136 -0.977 . . . . 1.6499999999999999 110.513 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -59.96 -39.98 87.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.435 -0.79 . . . . 1.8400000000000001 110.377 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -52.29 -43.95 64.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.19 -0.944 . . . . 2.5 110.3 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.674 HD22 HG13 ' A' ' 11' ' ' VAL . 2.1 tt -68.65 -40.02 80.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.079 -1.013 . . . . 0.85999999999999999 109.38 176.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.945 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -59.34 -40.01 85.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.319 -0.863 . . . . 0.40999999999999998 109.988 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -46.63 88.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 1.6100000000000001 109.504 175.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 64.1 t0 -60.02 -39.97 87.68 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.288 -0.882 . . . . 1.3600000000000001 109.746 174.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.86 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -65.5 -44.16 87.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.898 . . . . 1.1100000000000001 110.211 178.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.945 HD12 ' O ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -57.88 -53.2 60.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 1.55 110.197 -178.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.501 ' HG2' ' OD1' ' A' ' 26' ' ' ASN . 86.4 tt0 -62.51 -40.03 95.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 2.4100000000000001 110.765 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.8 tp60 -59.98 -41.89 93.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.087 -1.008 . . . . 2.3500000000000001 111.004 -172.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 28' ' ' ALA . 83.6 mt -63.9 -47.55 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.078 -1.014 . . . . 0.63 110.49 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -62.84 -51.48 66.89 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.799 -1.188 . . . . 2.9300000000000002 110.153 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.501 ' OD1' ' HG2' ' A' ' 22' ' ' GLU . 27.1 m120 -61.11 -41.32 96.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.262 -0.899 . . . . 1.79 110.785 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.823 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -105.66 -64.72 0.64 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.458 -1.457 . . . . 0.71999999999999997 109.458 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.823 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . 89.77 96.61 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.653 0.739 . . . . 1.21 110.581 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.473 ' O ' ' CG ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -178.05 83.04 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.595 -0.691 . . . . 1.5600000000000001 109.533 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -67.19 -43.7 81.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 2.1000000000000001 110.676 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.89 -51.2 53.51 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.83 -1.308 . . . . 0.56000000000000005 109.83 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 29.5 mttm -66.71 -38.39 86.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.017 -1.284 . . . . 2.9500000000000002 110.891 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.55 ' CD1' HG12 ' A' ' 24' ' ' ILE . 71.2 mt -62.09 -40.04 94.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.861 -1.149 . . . . 1.96 110.165 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.31 93.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.933 -1.105 . . . . 0.55000000000000004 109.472 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 59.3 tttp -59.98 -46.3 89.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.38 -0.825 . . . . 3.0800000000000001 110.793 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -70.02 -40.36 75.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.166 -0.958 . . . . 2.8500000000000001 111.895 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -102.56 -23.83 13.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.573 -1.33 . . . . 1.52 111.655 -168.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.653 ' O ' HG22 ' A' ' 39' ' ' ILE . 35.4 t -59.9 -43.69 94.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.879 -1.138 . . . . 1.25 110.32 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 38' ' ' SER . 19.8 tt 37.6 29.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 2.0499999999999998 110.547 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.507 ' N ' ' O ' ' A' ' 38' ' ' SER . 14.2 p -125.17 169.06 11.87 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.945 . . . . 1.1499999999999999 110.075 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -59.24 -23.47 69.77 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.977 1.514 . . . . 1.25 110.042 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.578 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -104.84 27.98 7.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.353 -0.842 . . . . 1.23 109.751 176.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.535 ' HA2' ' OG ' ' A' ' 38' ' ' SER . . . -75.59 -56.72 4.48 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.59 -1.804 . . . . 0.75 108.59 173.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -60.39 -39.94 89.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -1.134 . . . . 3.7000000000000002 110.626 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -96.34 -44.19 7.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.927 -1.108 . . . . 2.9900000000000002 110.736 -174.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 42' ' ' SER . . . -61.14 -36.71 92.77 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.532 -1.427 . . . . 1.1000000000000001 109.532 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.95 0.45 21.98 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.706 -1.357 . . . . 0.95999999999999996 109.706 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -170.38 78.01 0.08 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.241 -1.152 . . . . 1.54 109.187 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 45' ' ' ARG . 6.3 mt -82.73 -4.13 57.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.562 -0.711 . . . . 0.70999999999999996 110.204 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 5' ' ' ALA . . . 70.01 -137.33 28.13 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.103 -1.599 . . . . 0.60999999999999999 109.103 -176.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 2.6 mt-10 -104.24 135.07 46.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -1.097 . . . . 1.73 110.681 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.701 ' CE2' ' HB3' ' A' ' 6' ' ' ALA . 4.1 p90 -147.61 160.15 42.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.563 -0.711 . . . . 0.92000000000000004 109.593 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' A' ' 56' ' ' GLN . 6.4 ptm180 -90.02 170.28 10.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 4.1299999999999999 110.579 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -61.04 -14.36 22.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.244 -0.91 . . . . 5.04 110.612 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.401 ' C ' ' HG2' ' A' ' 56' ' ' GLN . . . -102.69 60.46 0.52 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.502 -1.439 . . . . 2.8399999999999999 109.502 -176.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.554 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 4.3 mm-40 -132.92 -61.96 0.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.066 -1.256 . . . . 2.02 109.735 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.527 ' HB3' HG12 ' A' ' 58' ' ' VAL . 5.9 ttp -106.16 -66.03 1.03 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.339 -0.944 . . . . 6.2199999999999998 111.243 -165.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.527 HG12 ' HB3' ' A' ' 57' ' ' MET . 2.9 p -154.07 137.69 10.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.898 -1.126 . . . . 1.78 110.599 -170.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.56 ' O ' ' N ' ' A' ' 61' ' ' PHE . 10.8 Cg_endo -57.98 -52.13 6.53 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.979 1.515 . . . . 1.3400000000000001 110.768 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 59' ' ' PRO . . . -35.53 -29.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.475 -0.766 . . . . 0.73999999999999999 110.46 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.56 ' N ' ' O ' ' A' ' 59' ' ' PRO . 45.9 t80 -58.05 -40.3 80.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.136 -0.977 . . . . 1.1799999999999999 110.152 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' PRO . 13.1 t70 -59.98 -40.64 89.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.035 -1.041 . . . . 1.8799999999999999 109.739 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 67' ' ' SER . 64.8 mttm -59.98 -50.55 73.32 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.399 -0.92 . . . . 3.7000000000000002 110.53 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.667 HG23 HG21 ' A' ' 74' ' ' THR . 7.1 p -70.83 -47.16 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.075 -1.016 . . . . 1.1899999999999999 110.657 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.535 ' N ' HG13 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -53.17 -30.04 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.797 -1.189 . . . . 0.97999999999999998 109.318 175.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 4.8 m-85 -96.29 2.67 53.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.38 -0.825 . . . . 2.2999999999999998 109.823 174.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 64' ' ' VAL . 20.1 t -94.76 -70.54 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 1.23 109.521 174.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.8 m -106.03 142.61 25.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 1.8300000000000001 109.952 174.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.1 164.54 35.4 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.916 1.482 . . . . 1.6399999999999999 110.487 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.864 HG13 HD12 ' A' ' 71' ' ' LEU . 7.1 p -57.13 170.56 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 1.74 109.955 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.864 HD12 HG13 ' A' ' 70' ' ' VAL . 3.5 mp 60.01 35.15 21.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.29 -0.881 . . . . 1.71 110.021 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . 16.3 tt0 -163.47 93.48 1.11 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 2.0099999999999998 109.95 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 72' ' ' GLU . 6.5 Cg_endo -53.46 144.25 51.75 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.935 1.492 . . . . 0.87 110.47 -177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.667 HG21 HG23 ' A' ' 64' ' ' VAL . 22.9 m -139.83 143.34 36.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -0.878 . . . . 0.64000000000000001 110.272 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' HA3' HG13 ' A' ' 85' ' ' ILE . . . 136.63 -178.48 18.83 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.368 -1.493 . . . . 0.52000000000000002 109.368 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.538 ' HG3' HD11 ' A' ' 21' ' ' LEU . 46.0 Cg_endo -73.64 136.52 45.08 Favored 'Cis proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.364 -2.348 . . . . 0.66000000000000003 110.555 -1.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' HG ' ' N ' ' A' ' 78' ' ' HIS . 55.7 tp -100.43 160.22 14.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.232 -0.918 . . . . 1.8999999999999999 110.42 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.443 ' N ' ' HG ' ' A' ' 77' ' ' LEU . 45.5 m80 -77.33 133.67 38.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.167 -0.958 . . . . 2.52 111.051 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.856 HG21 ' CE1' ' A' ' 84' ' ' HIS . 6.2 t -147.72 158.3 43.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -0.922 . . . . 0.73999999999999999 109.75 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -60.05 -30.41 69.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.075 -1.016 . . . . 3.0099999999999998 110.728 -176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -79.89 -10.02 59.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.094 -1.004 . . . . 1.26 110.704 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.83 -120.06 1.28 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.237 -1.545 . . . . 0.60999999999999999 109.237 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -129.77 129.99 44.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -1.117 . . . . 1.4299999999999999 109.736 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.856 ' CE1' HG21 ' A' ' 79' ' ' THR . 40.3 m170 -103.64 124.45 48.86 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.915 . . . . 0.60999999999999999 110.796 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.699 HG22 ' HB ' ' A' ' 9' ' ' ILE . 3.2 tt -108.56 127.72 64.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.891 -1.131 . . . . 0.34999999999999998 109.161 168.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.537 HG12 ' ND1' ' A' ' 8' ' ' HIS . 66.4 mt -129.99 133.84 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.987 -1.071 . . . . 0.46000000000000002 110.994 -169.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 1.008 ' HD2' HD12 ' A' ' 7' ' ' LEU . 14.6 ttmt -100.03 128.88 46.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 2.2400000000000002 109.375 170.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.807 ' O ' HD23 ' A' ' 89' ' ' LEU . 23.3 t -106.12 131.65 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.88 110.631 -173.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 88' ' ' VAL . 43.7 mt -139.29 -167.68 2.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.343 -0.848 . . . . 0.75 109.273 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 53.0 m-85 32.02 -86.73 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 122.062 -0.399 . . . . 2.9300000000000002 111.492 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 89' ' ' LEU . 67.0 ttt180 60.05 48.67 8.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.736 -1.227 . . . . 3.0899999999999999 110.827 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.788 HD22 ' HB1' ' A' ' 1' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.996 -1.002 . . . . 3.75 110.154 175.717 . . . . . . . . 2 2 . 1 stop_ save_